Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus

European Journal of Neuroscience

Volumn 18, Issue 3, 2003, Pages 524-534

  Hoffman, Alexander F ^a   Riegel, Arthur C ^a   Lupica, Carl R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Electrophysiology; GABA; Glutamate; Interneurons; Marijuana; Rat

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; RIMONABANT;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DEPOLARIZATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; NERVE ENDING; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYNAPSE;

ANIMALS; CANNABINOIDS; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; INTERNEURONS; MALE; MORPHOLINES; NAPHTHALENES; NEURAL INHIBITION; NEURONS; PIPERIDINES; PYRAMIDAL CELLS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SYNAPSES; TISSUE DISTRIBUTION;

EID: 0041920807     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02773.x     Document Type: Article

References (57)

1. Abood, M.E. & Martin, B.R. (1992) Neurobiology of marijuana abuse. Trends Pharmacol. Sci., 13, 201-206.
2. Acsady, L., Arabadzisz, D. & Freund, T.F. (1996a) Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in rat hippocampus. Neuroscience, 73, 299-315.
3. Acsady, L., Gorcs, T.J. & Freund, T.F. (1996b) Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience, 73, 317-334.
4. Ameri, A. (1999) The effects of cannabinoids on the brain. Prog. Neurobiol., 58, 315-348.
5. Ameri, A., Wilhelm, A. & Simmet, T. (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br. J. Pharmacol., 126, 1831-1839.
6. Blasco-Ibanez, J.M., Martinez-Guijarro, F.J. & Freund, T.F. (1998) Enkephalin-containing interneurons are specialized to innervate other interneurons in the hippocampal CA1 region of the rat and guinea-pig. Eur. J. Neurosci., 10, 1784-1795.
7. Blasco-Ibenez, J.M. & Freund, T.F. (1995) Synaptic input of horizontal interneurons in stratum oriens of the hippocampal CA1 subfield: structural basis of feed-back activation. Eur. J. Neurosci., 7, 2170-2180.
8. Carlson, G., Wang, Y. & Alger, B.E. (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nature Neurosci., 5, 723-724.
9. Chrobak, J.J. & Buzsáki, G. (1998) Gamma oscillations in the entorhinal cortex of the freely behaving rat. J. Neurosci., 18, 388-398.
10. Cobb, S.R., Buhl, E.H., Halasy, K., Paulsen, O. & Somogyi, P. (1995) Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature, 378, 75-78.
11. Cohen, G.A., Doze, V.A. & Madison, D.V. (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron, 9, 325-335.
12. Cope, D.W., Maccaferri, G., Marton, L.F., Roberts, J.D., Cobden, P.M. & Somogyi, P. (2002) Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience, 109, 63-80.
13. Davies, S.N., Pertwee, R.G. & Riedel, G. (2002) Functions of cannabinoid receptors in the hippocampus. Neuropharmacology, 42, 993-1007.
14. Deadwyler, S.A., Hampson, R.E., Bennett, B.A., Edwards, T.A., Mu, J., Pacheco, M.A., Ward, S.J. & Childers, S.R. (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels, 1, 121-134.
15. Deadwyler, S.A., Hampson, R.E., Mu, J., Whyte, A. & Childers, S. (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther., 273, 734-743.
16. Dodt, H.U. & Zieglgansberger, W. (1990) Visualizing unstained neurons in living brain slices by infrared DIC-videomicroscopy. Brain Res., 537, 333-336.
17. Freund, T.F. & Buzsaki, G. (1996) Interneurons of the hippocampus. Hippocampus, 6, 347-470.
18. Gaoni, Y. & Mechoulam, R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 86, 1646.
19. Gerdeman, G.L., Partridge, J.G., Lupica, C.R. & Lovinger, D.M. (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosciences, 26, 184-192.
20. Gerdeman, G.L., Ronesi, J. & Lovinger, D.M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neurosci., 5, 446-451.
21. Gulyas, A.I., Gorcs, T.J. & Freund, T.F. (1990) Innervation of different peptide-containing neurons in the hippocampus by GABAergic septal afferents. Neuroscience, 37, 31-44.
22. Gulyás, A.I., Hájos, N. & Freund, T.F. (1996) Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J. Neurosci., 16, 3397-3411.
23. Hajos, N. & Freund, T.F. (2002) Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology, 43, 503-510.
24. Hajos, N., Katona, I., Naiem, S.S., Mackie, K., Ledent, C., Mody, I. & Freund, T.F. (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci., 12, 3239-3249.
25. Hajos, N., Ledent, C. & Freund, T.F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 106, 1-4.
26. Hajos, N. & Mody, I. (1997) Synaptic communication among interneurons: properties of spontaneous IPSCs in morphologically identified cells. J. Neurosci., 17, 8427-8442.
27. Harris, K.M., Marshall, P.E. & Landis, D.M. (1985) Ultrastructural study of cholecystokinin-immunoreactive cells and processes in area CA1 of the rat hippocampus. J. Comp. Neurol., 233, 147-158.
28. Heyser, C.J., Hampson, R.E. & Deadwyler, S.A. (1993) Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J. Pharmacol. Exp. Ther., 264, 294-307.
29. Hoffman, A.F. & Lupica, C.R. (2000) Mechanisms of cannabinoid inhibition of GABA (A) synaptic transmission in the hippocampus. J. Neurosci., 20, 2470-2479.
30. Hoffman, A.F. & Lupica, C.R. (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol., 85, 72-83.
31. Jennings, E.A., Vaughan, C.W. & Christie, M.J. (2001) Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. J. Physiol. (Lond.), 534, 805-812.
32. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E.S., Mackie, K. & Freund, T.F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci., 19, 4544-4558.
33. Lacaille, J.C., Mueller, A.L., Kunkel, D.D. & Schwartzkroin, P.A. (1987) Local circuit interactions between oriens/alveus interneurons and CA1 pyramidal cells in hippocampal slices: Electrophysiology and morphology. J. Neurosci., 7, 1979-1993.
34. Lupica, C.R. (1995) δ and μ enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J. Neurosci., 15, 737-749.
35. Marsicano, G. & Lutz, B. (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci., 11, 4213-4225.
36. Martin, B.R., Mechoulam, R. & Razdan, R.K. (1999) Discovery and characterization of endogenous cannabinoids. Life Sci., 65, 573-595.
37. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
38. McBain, C.J. & Fisahn, A. (2001) Interneurons unbound. Nature Rev. Neurosci., 2, 11-23.
39. Mechoulam, R., Fride, E. & Di Marzo, V. (1998) Endocannabinoids. Eur. J. Pharmacol., 359, 1-18.
40. + conductance in hippocampal interneurons. J. Neurosci., 17, 4994-5003.
41. Misner, D.L. & Sullivan, J.M. (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci., 19, 6795-6805.
42. Murray, J.B. (1986) Marijuana's effects on human cognitive functions, psychomotor functions, and personality. J. Gen. Psychol., 113, 23-55.
43. Neher, E. (1992) Correction for liquid junction potentials in patch clamp experiments. Meth. Enzymol., 207, 123-131.
44. Nunzi, M.G., Gorio, A., Milan, F., Freund, T.F., Somogyi, P. & Smith, A.D. (1985) Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus. J. Comp. Neurol., 237, 485-505.
45. Ohno-Shosaku, T, Maejima, T. & Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729-738.
46. Ohno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zimmer, A. & Kano, M. (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci., 22, 3864-3872.
47. Pawelzik, H., Hughes, D.I. & Thomson, A.M. (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurons in CA1 of the adult rat hippocampus. J. Comp. Neurol., 443, 346-367.
48. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O.J. (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci., 21, 109-116.
49. Stella, N., Schweitzer, P. & Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
50. Sullivan, J.M. (1999) Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol., 82, 1286-1294.
51. Svoboda, K.R., Adams, C.E. & Lupica, C.R. (1999) Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J. Neurosci., 19, 85-95.
52. Svoboda, K.R. & Lupica, C.R. (1998) Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J. Neurosci., 18, 7094-7098.
53. Traub, R.D., Spruston, N., Soltesz, I., Konnerth, A., Whittington, M.A. & Jefferys, G.R. (1998) Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity. Prog. Neurobiol., 55, 563-575.
54. Tsou, K., Mackie, K., M.C. & Walker, J.M. (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience, 93, 969-975.
55. Whittington, M.A., Traub, R.D., Faulkner, H.J., Jefferys, J.G.R. & Chettiar, K. (1998) Morphine disrupts long-range synchrony of gamma oscillations in hippocampal slices. Proc. Natl Acad. Sci. USA, 95, 5807-5811.
56. Wilson, R.I., Kunos, G. & Nicoll, R.A. (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron, 31, 453-462.
57. Wilson, R.I. & Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature, 410, 588-592.